Cargando…
Proximity extension assay testing reveals novel diagnostic biomarkers of atypical parkinsonian syndromes
OBJECTIVE: The high degree of clinical overlap between atypical parkinsonian syndromes (APS) and Parkinson’s disease (PD) makes diagnosis challenging. We aimed to identify novel diagnostic protein biomarkers of APS using multiplex proximity extension assay (PEA) testing. METHODS: Cerebrospinal fluid...
Autores principales: | Jabbari, Edwin, Woodside, John, Guo, Tong, Magdalinou, Nadia K, Chelban, Viorica, Athauda, Dilan, Lees, Andrew J, Foltynie, Thomas, Houlden, Henry, Church, Alistair, Hu, Michele TM, Rowe, James B, Zetterberg, Henrik, Morris, Huw R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585258/ https://www.ncbi.nlm.nih.gov/pubmed/30867224 http://dx.doi.org/10.1136/jnnp-2018-320151 |
Ejemplares similares
-
Combining biomarkers for prognostic modelling of Parkinson’s disease
por: Vijiaratnam, Nirosen, et al.
Publicado: (2022) -
The Addenbrooke's Cognitive Examination for the differential diagnosis and longitudinal assessment of patients with parkinsonian disorders
por: Rittman, Timothy, et al.
Publicado: (2013) -
Clinical utility of dopamine transporter single photon emission CT (DaT-SPECT) with ((123)I) ioflupane in diagnosis of parkinsonian syndromes
por: Bajaj, Nin, et al.
Publicado: (2013) -
Automated Brainstem Segmentation Detects Differential Involvement in Atypical Parkinsonian Syndromes
por: Bocchetta, Martina, et al.
Publicado: (2020) -
Features of GBA-associated Parkinson’s disease at presentation in the UK Tracking Parkinson’s study
por: Malek, Naveed, et al.
Publicado: (2018)